 | • レポートコード：MRC2304A118 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、254ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に5,645.78百万ドルであった世界のアブレーション技術市場規模が2022年に6,536.99百万ドルに到達し、2027年までにCAGR 15.96％で成長して13,728.63百万ドルへと拡大すると予測しています。当調査資料では、アブレーション技術の世界市場について多角的な視点から分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品タイプ別（凍結アブレーション、電気アブレーション、水熱アブレーション、レーザー/光アブレーション、マイクロ波アブレーション）分析、技術別（非熱式、熱式）分析、エンドユーザー別（クリニック、地域医療、病院＆外科センター、腫瘍センター）分析、用途別（癌、循環器疾患、美容外科、婦人科、眼科）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめました。なお、当書内の企業情報としては、Abbott Laboratories、AngioDynamics, Inc.、AtriCure, Inc.、Biosense Webster, Inc、BIOTRONIK SE & Co KG、Boston Scientific Corporation、CardioFocus, Inc.、CONMED Corporation、Edwards Lifesciences Corporation、Galil Medical Inc.などが掲載されています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のアブレーション技術市場規模：製品タイプ別 - 凍結アブレーションの市場規模 - 電気アブレーションの市場規模 - 水熱アブレーションの市場規模 - レーザー/光アブレーションの市場規模 - マイクロ波アブレーションの市場規模 ・世界のアブレーション技術市場規模：技術別 - 非熱式アブレーションの市場規模 - 熱式アブレーションの市場規模 ・世界のアブレーション技術市場規模：エンドユーザー別 - クリニックにおける市場規模 - 地域医療における市場規模 - 病院＆外科センターにおける市場規模 - 腫瘍センターにおける市場規模 ・世界のアブレーション技術市場規模：用途別 - 癌における市場規模 - 循環器疾患における市場規模 - 美容外科における市場規模 - 婦人科における市場規模 - 眼科における市場規模 ・世界のアブレーション技術市場規模：地域別 - 南北アメリカのアブレーション技術市場規模 アメリカのアブレーション技術市場規模 カナダのアブレーション技術市場規模 ブラジルのアブレーション技術市場規模 ... - アジア太平洋のアブレーション技術市場規模 日本のアブレーション技術市場規模 中国のアブレーション技術市場規模 インドのアブレーション技術市場規模 韓国のアブレーション技術市場規模 台湾のアブレーション技術市場規模 ... - ヨーロッパ/中東/アフリカのアブレーション技術市場規模 イギリスのアブレーション技術市場規模 ドイツのアブレーション技術市場規模 フランスのアブレーション技術市場規模 ロシアのアブレーション技術市場規模 ... - その他地域のアブレーション技術市場規模 ・競争状況 ・企業情報 |
The Global Ablation Technology Market size was estimated at USD 5,645.78 million in 2021 and expected to reach USD 6,536.99 million in 2022, and is projected to grow at a CAGR 15.96% to reach USD 13,728.63 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Ablation Technology to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Cryoablation, Electrical, Hydrothermal, Laser/Light, Microwave, Radiofrequency, and Ultrasound.
Based on Technology, the market was studied across Non-thermal and Thermal. The Non-thermal is further studied across Cryotherapy and Hydromechanical. The Thermal is further studied across Electrical, Hydrothermal, Light, Microwave, Radiation, Radiofrequency, and Ultrasound.
Based on End-user, the market was studied across Clinics, Community Healthcare, Hospitals and Surgical Centers, and Oncology Centers.
Based on Application, the market was studied across Cancer, Cardiovascular Disease, Cosmetic Surgery, Gynecology, Ophthalmology, Orthopedic Treatment, Pain Management, and Urology.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Ablation Technology market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ablation Technology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Ablation Technology Market, including Abbott Laboratories, AngioDynamics, Inc., AtriCure, Inc., Biosense Webster, Inc, BIOTRONIK SE & Co KG, Boston Scientific Corporation, CardioFocus, Inc., CONMED Corporation, Edwards Lifesciences Corporation, Galil Medical Inc., Halyard Health, Inc., Hologic, Inc., Japan Lifeline Co., Ltd., Kardium Inc, Lepu Medical Technology Beijing Co Ltd., Medtronic, PLC, Olympus Corporation, OSYPKA AG, Siemens Healthineers AG, Smith & Nephew PLC, Stereotaxis Inc, SympleSurgical Inc., and Thermedical, Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Ablation Technology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Ablation Technology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Ablation Technology Market?
4. What is the competitive strategic window for opportunities in the Global Ablation Technology Market?
5. What are the technology trends and regulatory frameworks in the Global Ablation Technology Market?
6. What is the market share of the leading vendors in the Global Ablation Technology Market?
7. What modes and strategic moves are considered suitable for entering the Global Ablation Technology Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of ablation procedures
5.1.1.2. Rising geriatric population along with rising incidence of cancer
5.1.1.3. Growing prevalence of cardiovascular diseases
5.1.2. Restraints
5.1.2.1. Reuse and reprocessing of devices in developing countries
5.1.2.2. Pain and risk associated with ablation procedures
5.1.3. Opportunities
5.1.3.1. Growing adoption of ablation procedures in emerging economies
5.1.3.2. Emergence of next-generation ablation products and technologies
5.1.4. Challenges
5.1.4.1. High cost of ablation process and inflexible regulatory approval process
5.2. Cumulative Impact of COVID-19
6. Ablation Technology Market, by Product Type
6.1. Introduction
6.2. Cryoablation
6.3. Electrical
6.4. Hydrothermal
6.5. Laser/Light
6.6. Microwave
6.7. Radiofrequency
6.8. Ultrasound
7. Ablation Technology Market, by Technology
7.1. Introduction
7.2. Non-thermal
7.3.1. Cryotherapy
7.3.2. Hydromechanical
7.3. Thermal
7.4.1. Electrical
7.4.2. Hydrothermal
7.4.3. Light
7.4.4. Microwave
7.4.5. Radiation
7.4.6. Radiofrequency
7.4.7. Ultrasound
8. Ablation Technology Market, by End-user
8.1. Introduction
8.2. Clinics
8.3. Community Healthcare
8.4. Hospitals and Surgical Centers
8.5. Oncology Centers
9. Ablation Technology Market, by Application
9.1. Introduction
9.2. Cancer
9.3. Cardiovascular Disease
9.4. Cosmetic Surgery
9.5. Gynecology
9.6. Ophthalmology
9.7. Orthopedic Treatment
9.8. Pain Management
9.9. Urology
10. Americas Ablation Technology Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Ablation Technology Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Ablation Technology Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. AngioDynamics, Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. AtriCure, Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Biosense Webster, Inc
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. BIOTRONIK SE & Co KG
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Boston Scientific Corporation
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. CardioFocus, Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. CONMED Corporation
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Edwards Lifesciences Corporation
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Galil Medical Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Halyard Health, Inc.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Hologic, Inc.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Japan Lifeline Co., Ltd.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Kardium Inc
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Lepu Medical Technology Beijing Co Ltd.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Medtronic, PLC
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Olympus Corporation
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. OSYPKA AG
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Siemens Healthineers AG
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Smith & Nephew PLC
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Stereotaxis Inc
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. SympleSurgical Inc.
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Thermedical, Inc
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing